Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs

Although CAR-T cells are widely used to treat cancer, efficiency of CAR-T cell cytolytic responses has not been carefully examined. We engineered CAR specific for HMW-MAA (high-molecular-weight melanoma-associated antigen) and evaluated potency of CD8+ CAR-T cells to release cytolytic granules and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Anikeeva, Nadia, Panteleev, Sergey, Mazzanti, Nicholas W., Terai, Mizue, Sato, Takami, Sykulev, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452787/
https://www.ncbi.nlm.nih.gov/pubmed/34371020
http://dx.doi.org/10.1016/j.jbc.2021.101033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452787/
https://www.ncbi.nlm.nih.gov/pubmed/34371020
http://dx.doi.org/10.1016/j.jbc.2021.101033

Ejemplares similares